Nuclear Fuel Licensing Gets a Boring Paperwork Refresh
Published Date: 12/10/2025
Notice
Summary
The Nuclear Regulatory Commission is renewing its info collection about scheduling licenses for new, safer nuclear fuels that last longer and use more energy. This affects nuclear companies who need to share their plans with the NRC. Comments on this renewal are open until February 9, 2026, with no new costs expected, just smoother licensing updates.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13687, Implementation of the National Environmental Policy Act
The Nuclear Regulatory Commission is updating how it follows the National Environmental Policy Act to make reviews faster, clearer, and less of a hassle. These changes affect anyone applying for nuclear licenses or permits, cutting down on paperwork and focusing only on important environmental impacts. You’ve got until August 21, 2026, to share your thoughts before the new rules take shape!
2026-12067, Fee Schedules; Fee Recovery for Fiscal Year 2026
The Nuclear Regulatory Commission is updating its fees for licenses, inspections, and special projects starting August 17, 2026. These changes make sure the NRC covers nearly all its costs while setting clear fee limits to keep prices predictable and fair. If you hold a license or apply for one, expect some fee adjustments that help the NRC run smoothly and efficiently.
2026-08015, Generic Environmental Impact Statement for Licensing of New Nuclear Reactors
The Nuclear Regulatory Commission just updated the rules for checking the environmental impact of new nuclear reactors. This makes it easier and faster to review many reactors by using a common set of environmental factors, while still looking closely at unique site details. The new rules kick in on May 26, 2026, helping companies save time and money when applying to build new reactors.
2026-06048, Risk-Informed, Technology-Inclusive Regulatory Framework for Advanced Reactors
The Nuclear Regulatory Commission is updating its rules to make it easier and faster to approve new types of nuclear reactors, not just the old light-water ones. This change helps companies building advanced reactors by using smarter, risk-based rules that fit new technology. The new rules start on April 29, 2026, and could save time and money for the nuclear industry and the public.
2026-04823, Fee Schedules; Fee Recovery for Fiscal Year 2026
The Nuclear Regulatory Commission (NRC) is updating its fees for licenses, inspections, and special projects for fiscal year 2026. These changes aim to cover nearly all NRC costs and set fixed fee limits to boost efficiency and fairness. If you’re involved with the NRC, get ready for new fees by September 30, 2026, and don’t miss the April 13 deadline to share your thoughts!
2025-14147, Fee Schedules; Fee Recovery for Fiscal Year 2025
The U.S. Nuclear Regulatory Commission fixed a typo in their fee schedule for 2025. This update affects companies and government agencies that pay licensing and inspection fees, making sure the right amounts are charged. The corrected fees kick in soon, so everyone can plan their budgets without surprises!
Previous / Next Documents
Previous: 2025-22421, Information Collection: NRC Forms 541 and 541A, Uniform Low-Level Radioactive Waste Manifest Container and Waste Description and Continuation Page
The Nuclear Regulatory Commission is renewing its approval to collect info using NRC Forms 541 and 541A, which track low-level radioactive waste shipments. This affects companies handling this waste, who must keep using these forms with no big changes or extra costs. You can share your thoughts by February 9, 2026, to help shape the process.
Next: 2025-22424, Grant of Interim Extension of the Term of U.S. Patent No. 7,319,099; Bitopertin (GlyT1 inhibitor) Oral Tablets
Hoffman-La Roche just scored a one-year extra patent life for their drug Bitopertin because the FDA’s approval process is still underway. This means the company keeps exclusive rights to sell Bitopertin oral tablets until December 17, 2026, giving them more time to make money before others can copy it. If the FDA takes longer, they can get up to five one-year extensions, so the clock keeps ticking in their favor!